MRNA vs ROP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 03, 2026

MRNA

53.5
AI Score
VS
ROP Wins

ROP

58.4
AI Score

Investment Advisor Scores

MRNA

54score
Recommendation
HOLD

ROP

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MRNA ROP Winner
Forward P/E 23.0415 16.4474 ROP
PEG Ratio 0 1.4603 Tie
Revenue Growth -29.8% 11.3% ROP
Earnings Growth -85.1% 59.2% ROP
Tradestie Score 53.5/100 58.4/100 ROP
Profit Margin -145.2% 21.1% ROP
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, ROP is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.